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Introduction. Quick thrombolysis after stroke improved clinical outcomes. The study objective was to shorten door-to-needle time
for thrombolysis. Methods. After identifying the sources of in-hospital delays, we developed a protocol with a parallel algorithm
and recruited nurse practitioners into the acute stroke team. We applied the new protocol on stroke patients from October 2009
to September 2010. Patients from the previous two years were used for comparison. Results. For ischemic stroke patients within
3hours of onset, the median time from arrival to computed tomography scanning was reduced from 29 to 20minutes (P<0.001)
and the median time from arrival to neurology evaluation decreased from 61 to 43minutes (P<0.001). For those patients who
receivedthrombolysis,themediandoor-to-needletimewasshortenedfrom68.5to58minutes(P<0.05).Conclusions.Theparallel
thrombolysis protocol successfully improved the median door-to-needle time to below the guideline-recommended 60minutes.
1.Introduction
The introduction of intravenous recombinant tissue plas-
minogen activator (rtPA) has revolutionized the manage-
ment of acute ischemic stroke (AIS). Treatment with rtPA
has been shown to improve patients’ outcomes at 3 months;
however, its eﬀectiveness decreased with time from the
onset of stroke symptoms [1, 2]. Many stroke patients eli-
gibleforthrombolysiswerenottreatedappropriatelybecause
of delayed presentation to the hospital or delayed exami-
nations and management in the hospital. Although delays
are mainly caused by patients themselves [3], it should be
possible to minimize the in-hospital delay. According to the
recommendations made by the National Institute of Neu-
rological Disorders and Stroke, a patient with AIS should
receive rtPA within 60 minutes of arrival at the emergency
department (ED) [4]. A pilot study to address the quality of
acute stroke care in 4 states of the US found that less than
20% of the patients treated with intravenous rtPA received
it within 60 minutes of arrival [5]. A quasi-experimental
trial(TheStrokePracticeImprovementNetwork)toimprove
adherence to stroke performance measures concluded that
the implementation of site-speciﬁc interventions did not in-
crease the proportion of delivery of thrombolytic therapy
within one hour of hospital arrival during the 6-month in-
tervention period [6].
In Taiwan, only a minority of stroke patients are treated
with rtPA. A nationwide study (Taiwan Stroke Registry)
showed that 10.42% of AIS patients arriving within 2 hours
of onset were treated with rtPA [7]. Although a study indi-
catedthattheadoptionoflessrestrictiveexclusioncriteriafor
rtPA signiﬁcantly increased the number of patients eligible
for thrombolysis, there were still only 6.3% of patients who
arrived within 3 hours of stroke onset received thrombolytic
therapy [8]. Insuﬃcient time to complete required studies
was a main reason for exclusion from rtPA. Thus, this study2 Stroke Research and Treatment
was aimed to determine if the modiﬁcation of protocol
shortened the in-hospital delay and facilitated thrombolytic
therapy.
2.MaterialsandMethods
This was a before-and-after study to investigate the eﬀective-
ness of implementation of a new thrombolysis protocol. Our
institution is a 1000-bed community hospital serving a city
and its adjoining rural area of around 500,000 inhabitants
in southern Taiwan. The study population consisted of all
AIS patients directly presenting to the ED within 3 hours of
stroke onset in the one-year period from October 2009 to
September 2010 (Period II) after the implementation of the
new thrombolysis protocol. The major modiﬁcation is that
a nurse practitioner (NP) was designated to coordinate the
newly designed parallel pathway for candidate patients. The
control group comprised those patients who presented in
the two-year period from October 2007 to September 2009
(Period I). The number of neurologists (ﬁve) on the acute
stroke team and the number of computed tomography (CT)
scanners (two) in the study hospital did not change during
these two periods.
A standardized data abstraction form has been used
in the registration of stroke patients in our institute since
September 2006. We recorded the demographics, clinical
characteristics, laboratory ﬁndings, radiological character-
istics, and medications before and during hospitalization
of the patients. The stroke severity was recorded on
presentation by National Institute of Health Stroke Scale
(NIHSS). The exact time of arrival at ED, evaluation by
neurologists, receiving CT scans, and onset of thrombolysis
were collected prospectively by a trained study nurse. The
details in Taiwan Stroke Registry with the similar design had
been described elsewhere [7]. The outcome recorded in this
study included mortality and functional status at discharge,
presented by modiﬁed Rankin Scale (mRS) score. The status
at 3 months after discharge was obtained by the study nurse
from the medical record or personal/telephone interview.
The eligibility of thrombolysis for each patient was reviewed
retrospectively by two senior neurologists according to the
exclusion criteria set by the Department of Health and
Bureau of National Health Insurance in Taiwan [8]. Every
patient had a follow-up head CT scan 24 hours after
thrombolytic therapy. To evaluate the safety of thrombolysis,
we deﬁned symptomatic intracranial hemorrhage (SICH) as
any hemorrhage plus a neurological deterioration of 4 or
more points on the NIHSS [9]. The data collection had been
approved by the Institutional Review Board.
Byanalyzingouroriginalthrombolysisprotocoldesigned
in 2007 (Figure 1(a)), we divided the door-to-needle time
(DNT) into three steps: from ED arrival to CT scanning,
from CT scanning to neurology evaluation, and from neu-
rology evaluation to start of thrombolysis. The median
time of obtaining a CT scan had been within 25 min-
utes before this study [10]. The major in-hospital delays
occurred in the latter two steps. The prior protocol was an
ineﬃcient sequential algorithm (Figure 1(a)). Therefore, we
implemented a parallel protocol (Figure 1(b)) to minimize
the delays, and ED NPs were incorporated as coordinators
into the acute stroke team to collaborate with the physicians
and other departments.
We have a total of ﬁve NPs working morning and even-
ing shifts in the ED. The ED NPs help take care of all
emergency patients. However, once a patient was suspected
to have AIS at the triage desk, an NP was assigned to
this patient until rtPA was administered or the diagnosis
was proven otherwise. If the patient was a candidate for
thrombolysis based on the screening criteria, the designated
NP would soon notify the on-call neurologist by telephone
before the patient was sent for noncontrast CT scanning.
In addition, the NP coordinated the patient care, including
initial assessment of NIHSS and evaluation of suitability
for thrombolysis, collections of CT images and results of
laboratory tests, and preliminary explanation regarding the
beneﬁts and risks of thrombolytic therapy to the patients
and/or their family. Hence multiple tasks can be done in
parallel by the collaboration of the ED physician, the NP, the
on-call neurologist, and other departments.
While the neurologist was evaluating a candidate patient
for thrombolytic therapy, rtPA was brought to the bedside
unmixed pending further treatment decision making. If the
patient was determined eligible for thrombolysis, rtPA was
administered immediately after informed written consent
was obtained from the patient or next of kin. If thrombolysis
was not indicated, the drug box was returned unopened to
the pharmacy.
To investigate the eﬀectiveness of the new protocol,
we assessed time intervals between ED arrival and actions
including: CT scan, reports of blood tests, neurology eval-
uation, and thrombolysis. To monitor the eﬃciency of
thrombolysisovertime,wecomputedtherunningmedianof
DNTs at 3-month intervals in the control and study periods.
ThepatientswithmRS0-1wereconsideredashavingafavor-
able functional outcome.
Median values and interquartile ranges of the time
intervals were used for descriptive statistics because of their
nonnormal distributions. Comparison of median values was
done with the Mann-Whitney test. Student’s t-test was used
to evaluate diﬀerences in continuous variables with normal
distribution. Chi-square test or Fisher’s exact test was used
as appropriate to compare categorical data. A value of P<
0.05 was regarded as signiﬁcant. All statistical analyses were
performed using Windows SPSS version 15.0 (SPSS Inc.,
Chicago, ILL, USA).
3. Results
In Period I, a total of 1062 AIS patients were admitted, with
338 patients arriving within 3 hours. They were examined
using the original thrombolysis protocol. Of these 338
patients, 52 (15.4%) patients were eligible for thrombolysis.
In Period II, 586 patients with AIS were admitted and 139
of them arrived within 3 hours. Twenty (14.4%) patients
were indicated to have thrombolysis. Common reasons
for exclusion from treatment included age over 80 years,Stroke Research and Treatment 3
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Figure 1: The original thrombolysis protocol based on a sequential algorithm (a) and the new thrombolysis protocol based on a parallel
algorithm (b).
minor or rapidly improving stroke, severe stroke, history
of both diabetes and prior ischemic stroke, and elevated
blood pressure (Figure 2). During Period I, one patient
refused thrombolysis and 11 patients were either considered
ineligible by ED doctors or were unable to complete CT and
laboratory studies in time. During Period II, in addition to
the 20 eligible patients, one patient who met the exclusion
criteria because of age was treated as per family request.
Therefore, for patients within 3 hours of onset, the treatment
rate increased from 11.8% (40/338) to 15.1% (21/139)
between Periods I and II (Table 1). There was no signiﬁcant
diﬀerence in the proportion of eligible patients.4 Stroke Research and Treatment
1062 patients with
acute ischemic stroke
52 were eligible for
thrombolysis
286 were excluded because of
• Age >80 years: 55
• Minor (NIHSS <6) or rapidly improving stroke: 160
• Severe stroke (NIHSS >25): 23
• History of both diabetes and prior ischemic stroke: 53
• History of previous intracranial hemorrhage: 15
• Seizure at onset: 9
• Current use of anticoagulant with INR >1.3: 4
• Blood glucose concentration >400mg/dL: 6
• Blood glucose concentration <50mg/dL: 1
• aPTT >upper limit of normal: 1
∗Some patients met multiple exclusion criteria
40 were treated 11 considered
ineligible by ED Dr
1 refused treatment
338 arrived ≤3h o u r s
• Elevated blood pressure (systolic >185mm Hg or
diastolic >110mm Hg): 80
• Platelet count <100,000/mm3:5
(a)
586 patients with acute
ischemic stroke
139 arrived ≤3 hours
20 were eligible for
thrombolysis
119 were excluded because of
• Age >80 years: 37
• Minor (NIHSS <6)or rapidly improving stroke: 58
• Severe stroke (NIHSS >25): 16
• History of both diabetes and prior ischemic stroke: 18
•
•
History of previous intracranial hemorrhage: 1
Seizure at onset: 8
• Current use of anticoagulant with INR >1.3: 6
• Blood glucose concentration >400mg/dL: 0
• Blood glucose concentration <50mg/dL: 0
• aPTT >upper limit of normal: 1
∗Some patients met multiple exclusion criteria
21 were treated
1 with age >80 years
• Platelet count <100,000/mm3:6
• Elevated blood pressure (systolic >185mm Hg or
diastolic >110mm Hg): 26
(b)
Figure 2: Clinical results before (a) and after (b) the implementation of the new thrombolysis protocol.Stroke Research and Treatment 5
Table 1: Patients with acute ischemic stroke directly presenting to the emergency department within 3 hours of stroke onset.
2007/10–2009/9
(n = 338)
2009/10–2010/9
(n = 139) P value
Age, mean ± SD: y 69.1 ±12.57 1 .9 ±12.5 0.029
Female, n (%) 136 (40.2) 59 (42.4) 0.656
Time from onset to, median (IQR): min
Arrival 65 (34–108) 66 (36–117) 0.217
Time from arrival to, median (IQR): min
CT scan 29 (19–50) 20 (13–38) <0.001
Neurology evaluation 61 (40–96) 43 (31–61) <0.001
Eligible for rtPA, n (%) 52 (15.4) 20 (14.4) 0.782
Treated with rtPA, n (%) 40 (11.8) 21 (15.1) 0.331
CT: computed tomography; IQR: interquartile range; SD: standard deviation; rtPA: recombinant tissue plasminogen activator.
Table 2: Patients treated with thrombolytic therapy.
2007/10–2009/9
(n = 40)
2009/10–2010/9
(n = 21) P value
Age, mean ± SD: y 65.6 ±12.17 1 .3 ±13.3 0.095
Female, n (%) 12 (30.0) 9 (42.9) 0.315
Pretreatment NIHSS, median 16 18 0.451
Time from onset to, median (IQR): min
Arrival 38.5 (22–73) 54 (27–103) 0.151
Thrombolysis 112.5 (95–137) 121 (88–158) 0.796
A r r i v a lb e t w e e n2a n d3h o u r s ,n (%) 0 (0) 4 (19.0) 0.012
Time from arrival to, median (IQR): min
CT scan 16.5 (12–23) 14 (11–19) 0.248
PT/PTT 52 (46–58) 48 (39–60) 0.288
Neurology evaluation 46 (32–63) 37 (28–43) 0.026
Thrombolysis 68.5 (57–83) 58 (54–69) 0.035
ICU admission 133.5 (95–152) 116 (94–143) 0.230
mRS 0-1, n (%) 14 (35.0) 6 (28.6) 0.611
SICH, n (%) 5 (12.5) 2 (9.5) 1.000a
aFisher’s exact test.
CT: computed tomography; ICU: intensive care unit; IQR: interquartile range; mRS: modiﬁed Rankin Scale; NIHSS: National Institutes of Health Stroke
Scale; PT: prothrombin time; PTT: partial thromboplastin time; SD: standard deviation; SICH: symptomatic intracerebral hemorrhage; rtPA: recombinant
tissue plasminogen activator.
For all the patients with AIS directly presenting to the ED
within 3 hours of stroke onset, the median time from arrival
to CT examination decreased signiﬁcantly from 29 to 20
minutes. At the same time, the median time from arrival to
neurologyevaluationwasreducedconsiderablyfrom61to43
minutes (Table 1). For those patients treated with rtPA, the
implementationofthenewprotocolsigniﬁcantlyreducedthe
d o o r - t o - n e u r o l o g ye v a l u a t i o nt i m ef r o m4 6t o3 7m i n u t e s
and the DNT from 68.5 to 58 minutes (Table 2). The 3-
month running median of DNTs also decreased from 104 to
40 minutes over the 3-year period (Figure 3). The onset-to-
needle time was not changed despite longer onset-to-door
time during Period II, reﬂecting that we administered rtPA
to more patients with delayed presentation of more than 2
hours after onset (19% in Period II versus none in Period
I). This factor also contributes to a nonsigniﬁcant increase
in the proportion of thrombolysed patients. The time from
arrivaltoreportofprothrombintime/partialthromboplastin
time, remained around 50 minutes. Baseline NIHSS scores
and the proportion of patients with favorable outcome after
3 months did not change between the two periods.
4. Discussion
We demonstrated the signiﬁcant eﬀect on shortening DNT
of rtPA administration in this before-and-after comparison
in the same hospital. The major changes between the two
periods are the implementation of the parallel protocol
and the introduction of NPs as coordinators in ED. Since
intravenous rtPA should be administered within the narrow
3-hour time window, a substantial proportion of patients6 Stroke Research and Treatment
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Figure 3: Time series of the three-month running median of door-to-needle times.
whoarrivedearlydidnotreceivethrombolytictherapyowing
to in-hospital delays including: delayed physician evaluation,
neurologic consultation, neuroimaging, and laboratory tests
[11]. In-hospital delays can be shortened through the organ-
ization of a stroke team, the development of stroke pathways,
and the training of ED personnel [12]. Although recentstud-
i e sp r o v e dt h a tr t P Ai se ﬀective up to 4.5 hours after stroke
onset [13], its eﬀectiveness decays with the time between
onset and treatment [2]. Therefore, every eﬀort should be
taken to hasten the start of the treatment, and the target
treatment with rtPA should be within one hour of patient’s
arrival in the ED [14].
By using a parallel strategy to overcome the in-hospital
delays, our revised protocol eﬀectively reduced the median
time of DNT below the recommended 60 minutes. Rapid
identiﬁcation of potential candidates for thrombolysis is the
paramount ﬁrst step in order that neurology evaluation, CT
scans, and laboratory studies can be arranged immediately
upon ED arrival. However, this poses a challenge to busy
ED physicians. In Period II, an NP was soon assigned to a
thrombolytic candidate upon hospital arrival. After prelim-
inary screening, the NP notiﬁed the neurologist who made
the decision of thrombolysis. This practice could prevent
a busy ED physician from excluding patients who actually
qualify for treatment because of delayed examinations or
unfamiliarity with rtPA eligibility criteria, as we have shown
that 21% (11/52) of eligible patients were not treated in
Period I but all eligible patients were treated in Period II.
In one study, although the agreement for determination of
rtPA eligibility was good between ED attendings and stroke
neurologists, 18% of thrombolysis candidates were still
designated as ineligible by ED attendings and the proportion
was even higher for ED residents [15].
Physicians who are not neurologists tend not to give pa-
tients thrombolytic treatment [16]. ED physicians usually
did not administer rtPA until a neurologist was called in for
consultation, considering the high rate of SICH among the
Chinese-Taiwanese [17]. Because of the limited personnel
and funding resources in a community hospital setting, neu-
rologists are not available on a 24/7 basis at our institution.
Since a team approach is important for the successful im-
plementation of a stroke protocol [18] and NP care has
been shown to increase compliance with clinical practice
guidelines [19], we incorporated ED NPs into our acute
stroke tame. The Calgary Stroke Program has demonstrated
that the use of stroke NPs reduced the DNT from 90 to 60
minutes and the door-to-CT time from 60 to 30 minutes
[20]. Nonetheless, the role of NPs in our stroke team is
diﬀerent from that in the Calgary Stroke Program in two
aspects. First, the NPs are not dedicated stroke NPs and
they also carry out routine jobs in the ED. Second, they
coordinate and facilitate the whole care process, but not as
autonomous ED care providers [21]. The obvious drawbacks
areasfollows:theneurologistsstillneedtoassessthepatients
in person, and the NPs have to defer their work when a
stroke patient arrives. However, this has the advantage of not
increasing direct hospital costs.
ThrombolytictherapyinevitablycarriestheriskofSICH,
especially when there is any deviation from the preset criteria
[22, 23]. Hence stroke patients must be checked against a
lengthy list of exclusion criteria which require a detailed
time-consuming history taking. For this purpose, the NP
helpedcompletetheexclusionchecklistwhiletheneurologist
was on the way to the bedside. It could be a concern if
shortening of DNT might cause some patients to be throm-
bolysed without fulﬁlling strict criteria. In the present study,
the reduction in DNT was not associated with an increased
proportion of SICH and all the thrombolysed patients were
eligible except one patient aged over 80 years. Furthermore,
our revised protocol may prevent inappropriate use of rtPA
because the exclusion criteria were checked by both the NP
and the neurologist. Another concern regarding our practice
is that we do not wait for formal CT interpretation by radi-
ologists. Such practice seemed to be safe and did not increase
the risks of SICH [24].Stroke Research and Treatment 7
The introduction of a computerized in-hospital alert sys-
tem has signiﬁcantly reduced the time intervals from ED
arrival to evaluation steps and treatment [25]. However,
hospitals have to be equipped with computerized network
systems and have to develop the computer program. By
adoption of a parallel algorithm and recruitment of NPs into
the acute stroke team, our thrombolysis protocol has been a
success similar to the computerized system.
AlthoughthenewprotocolhasshortenedtheDNTbelow
60 minutes, it is far from satisfactory because ultraearly
thrombolysis (treatment within 70 minutes of stroke onset)
resulted in a much higher likelihood of good outcomes for
patients with moderate and severe strokes [26]. A recent
study has demonstrated that the median DNT could be
decreased to only 20 minutes in a university hospital setting
[27].Inthepresentstudy,thetimefromarrivaltoavailability
ofcoagulationtestswasnotimprovedsigniﬁcantly.Therefore
the time spent in the central laboratory blood analysis will
be a main limiting factor for further reduction of DNT.
One approach is to proceed to treatment pending the results
of prothrombin time or partial thromboplastin time unless
there is a clinical reason to expect abnormal results of these
tests [24]. Another approach is to use point-of-care devi-
ces for measurements of international normalized ratio for
patients taking oral anticoagulants or when information re-
garding anticoagulation is unavailable. The use of point-of-
care device (Coaguchek XS; Roche, Switzerland) saved an
average of 28 minutes in one study [28].
Despite the successful shortening of DNT in this study,
the percentage of stroke patients treated with rtPA is still
small. To overcome this problem, community programs to
educate patients to seek treatment sooner after a stroke
should be an integral component of stroke care. In addition,
an eﬀective prehospital stroke code system should be estab-
lished. Prehospital notiﬁcation by EMS not only shortened
the prehospital delay [29], but also reduced DNT [30, 31].
TheprenotiﬁcationensuresthattheCTisreadyandavailable
for the arriving stroke patient and makes it possible for the
stroke neurologist to already be at the ED when the patient
arrives. The combined eﬀect of shortening prehospital delay
and in-hospital delay would further decrease the treatment
time from symptom onset, resulting in improved patients’
outcomes.
This study does have several limitations. First, we did
not have statistical power to detect a diﬀerence in the rates
of thrombolysis between the two periods. However, we did
demonstrate that shortening of in-hospital delays might in-
crease the number of thrombolysed patients, especially for
thosewhoarrivedmorethantwohoursafteronset.Inclusion
of more patients with late arrivals might explain the lack
of a decrease in onset-to-needle time in the study period.
Second, the improvement in DNT might be partly due
to the continuing education and training of the medical
staﬀ. Third, we could not show an improvement in the 3-
month outcomes of patients. It takes many factors to achieve
favorable functional outcomes, including shortened onset-
to-needletime.Thecombinedeﬀectofdecreasedprehospital
and in-hospital delays can be explored in future studies.
5. Conclusions
It is possible to shorten the time intervals of stroke manage-
ment by assigning an NP as an ED coordinator of the parallel
thrombolysis protocol to overcome the speciﬁc sources of
delaysinacommunityhospitalsettingwithlimitedresources
and faculty. Our successful model may help to promote the
eﬃc i e n tu s eo fN P si nt e a m - b a s e dc a r ef o ra c u t es t r o k ep a -
tients.
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